key: cord-0847615-yrylqim6
authors: Baghchechi, Mohsen; Jaipaul, Navin; Jacob, Sharon E.
title: The rise and evolution of COVID-19
date: 2020-06-26
journal: Int J Womens Dermatol
DOI: 10.1016/j.ijwd.2020.06.006
sha: d2ffb3f970d8dc14c95cd9e3232e1d107854adda
doc_id: 847615
cord_uid: yrylqim6

Abstract Coronaviridae (CoV) is a large family of zoonotic viruses linked to a range of diseases from the common cold to the severe SARS-CoV and MERS-CoV epidemics. In 2019, a novel virus emerged from Wuhan, China characterized by a marked worldwide outbreak of respiratory illness. Prevention and containment became the prioritized intervention against COVID-19, coupled with a continued search for hallmarks of the disease which would allow early detection and provide insight to management and triage. Cutaneous findings associated with COVID include diffuse maculopapular rashes, livedo reticularis, and acro-ischemic ‘COVID toes’. These skin findings occurred anywhere from days before respiratory symptom onset to weeks after recovery, and predominantly in the child and adolescent population. The role of dermatologists can be expanded during this COVID-19 pandemic to help identify disease through cutaneous presentations.

Background Members of Coronaviridae (CoV) family are characterized by a single-stranded, positive sense ribonucleic acid (RNA) with a helical capsid. This enzoonotic virus can remain viably infectious even following capsid destruction through its ability to replicate within the cytoplasm of infected cells. While this family of viruses is mostly associated with the common cold, there are much more virulent species within the taxa (Brian et al., 2005) . Notably, the SARS-CoV epidemic was thought to originate in bats with the civet cat being the intermediate host prior to human infection (Guan et al, 2003) . In 2007, Cheng et al. published an ominous report alluding to the potential for catastrophic reemergence of a SARS-like disease, referencing the large reservoir of virus in mammals (Cheng et al., 2007) .

In December 2019, a cluster of patients in Wuhan, Hubei Province, China presented with severe atypical pneumonia, with experts coining the illness coronavirus disease 2019 (ECDC, 2020) . While the source of this viral outbreak remains elusive, it is noted that the original 27 cases linked to the Southern China's Wuhan Seafood Wholesale Market (ECDC, 2020) . This market is known for selling various bushmeat and other wild animals to the public for consumption, which was speculated to include an unidentified intermediate host for . Like SARS-CoV, bats are understood to be the main host of the COVID-19 virus.

On January 20 th , a 35-year old male residing in Washington state with recent travel exposure to in Wuhan, China was identified as the first case of COVID-19 in the United States (LiveScience, 2020) . The reproduction number of the virus is estimated to be an average of 3.28 (mean R 0 =3.28), indicating that each infected person is likely to pass disease to over 3 people . Fear of a rising epidemic emerged with the identification of four cases in Thailand, Japan and South Korea. It was postulated that an extended latency phase may occur during which infected individuals remained asymptomatic as two of the four cases reported no contact with the Wuhan Central Hospital or aforementioned market (Rothe et al., 2002) . Within 60 days, in response to the medical need surge overloading the medical care capacity in Wuhan, the Chinese government constructed and designated two new hospitals to care for the additional patients. In addition, reverse transcriptase polymerase chain reaction (RT-PCR) and next generation sequencing tests were made readily available to collect specimens of sputum, blood, stool and bronchoalveolar lavage fluid cultures, which lead to the discovery of a novel coronavirus, SARS CoV-2, now known as COVID-19 (Wu F et al., 2020) . Evolving epidemiologic evidence determined COVID-19s capacity to spread through human-to-human droplet transmissions, with airborne transfer under investigation (Wu P et al., 2020) . A subsequent study identified the presence of virus in stool samples of an infected host, suggesting the potential for fecal-oral spread (Holshue et al., 2020) .

A latency period that extended up to two weeks resulted in rapid spread of COVID-19 through asymptomatic individuals harboring the disease, with international travel hubs playing a vital role in global transmission. Modern internet infrastructure led to a rapid generation of global index cases (Dong et al., 2020) . In late January 2020, United States first travel restrictions targeted travel from China, the source of outbreak. Weeks later, additional travel bans extended to Europe and the United Kingdom. The World Health Organization (WHO) declared COVID-19 a pandemic on March 11, 2020, with a global case total over 100,000. As of June 10, 2020, the worldwide confirmed COVID-19 case total eclipsed 7.1 million with greater than 400,000 deaths spanning across 6 continents ( Figure 1 ; CDC, 2020). The United States surpassed China in the number of confirmed COVID-19 cases and deaths by March 31, 2020, and current case totals as of June 10, 2020 exceed 1.9 million along with over 110,000 deaths, with reports in all 50 states (CDC, 2020) .

In order to help curtail the spread of COVID-19, cruise ships were detained to hold passengers onboard in a 14-day quarantine. For example, a Diamond Princess cruise ship discovered to harbor infected persons was docked outside California (Saey, 2020) . This Diamond Princess cruise ship accounted for over 700 infected crew and passengers onboard a tightly packed vessel harboring over 3,700 individuals. Cruise lines create the perfect environment for infection to run rampant, as seen in the past with norovirus outbreaks causing widespread gastrointestinal distress. Unfortunately for the passengers not infected, they had to wait through the same protocol until the ship was able to dock safely. For this reason, the Center for Disease Control and Prevention (CDC) issued a public warning against traveling on any cruise ships for the time being, especially if considered a high-risk individual (CDC, 2019). As of March 14, the CDC Director issued a 'no sail order', where cruise ships will voluntarily remain out of service from US ports for the next thirty days (CDC, 2020). The 'no sail order' was extended on April 9

to continue for a 100 day period unless the CDC director or Secretary of Health and Human Services declares COVID-19 to no longer be a public health emergency, in which the order can be terminated early.

Clinical symptoms range from mild respiratory illness to acute respiratory distress syndrome (ARDS). The original cohort of patients in Wuhan presented with fever, cough and dyspnea along with corresponding chest CT imaging illustrating bilateral ground glass opacities, and a notable paucity of upper respiratory tract infection hallmarks, such as rhinorrhea, pharyngitis or sinusitis (Bernheim et al., 2020; Lee et al., 2020) ; Assiri et al., 2020) . This rapid progression to ARDS is believed to be a result of the virus homing in on lower respiratory epithelium for attachment and infection . Researchers suggest a relationship exists between this SARS CoV-2 and the previous SARS CoV-1 and MERS CoV epidemics. All three diseases originate from the genus betacoronovirus and are discovered to spread through respiratory droplets (Peeri et al., 2020) . There is an 82% genomic sequence similarity between COVID-19 and SARS CoV-1 and 50% with MERS . Lab findings in COVID-19 show lymphocytopenia, with depletion of both CD4+ and CD8+ T cells in over 80% of presenting patients (Guan et al., 2020) . Liver injury is an emerging complication with COVID-19 and appears to be associated with severe disease phenotype .

Published reported skin findings continue to evolve since the COVID-19 pandemic began (Table 1) . A Chinese study claimed less than 1% incidence of cutaneous manifestations, while an Italian cohort reported over 20%, suggesting presentational differences in subset populations (Tang et al., 2020; Sachdeva et al., 2020; Recalcati, 2020) . The manifestations ranged from maculopapular exanthems, petechial rashes, pernio-like findings, to vesicular lesions (Tammaro et al., 2020; Galvan Casas et al., 2020; Bouaziz et al., 2020; Manalo et al., 2020) . Of note, many cases occurred in the child and adolescent population, such as the pernio-like lesions of the feet coined 'COVID toes' (Kolivras et al., 2020; Recalcati et al., 2020; Landa et al., 2020) . These skin presentations have the potential to confound diagnosis of COVID-19 early on, as they can simulate other infections (Lu et al., 2020) . One such case was presented as a patient with a petechial rash given an original diagnosis of Dengue fever, that was later confirmed to be COVID-19 related (Mungmungpuntipantip and Wiwanitkit, 2020; Joob and Wiwanitkit, 2020) .

There is high variability reported in timing of skin manifestations, with some studies identifying skin findings days before respiratory signs, while others weeks after recovery. Researchers speculate that COVID-19 skin findings are caused by an inflammatory response to the infection that results in a complement mediated microvascular injury (Magro et al., 2020) . Some reports discuss the difficulty confirming that cutaneous manifestations are specific for SARS-CoV-2, as many critically ill patients receive multiple medication regimens that can express similar cutaneous findings (Young and Fernandez, 2020) . Although there is no necessary treatment for COVID-related cutaneous manifestations, dermatologists should follow The American Academy of Dermatology (AAD) guidance when prescribing immunosuppressive agents for autoimmune mediated conditions normally treated with biologics (AAD, 2020).

Another novel phenomenon associated with COVID-19 has been a Kawasaki-like syndrome currently termed hyperinflammatory shock, or more specifically pediatric inflammatory multisystem syndrome (PIMS) (Morand et al., 2020) . A cluster of reported cases in previously healthy children presented with high fevers, conjunctivitis, rash and refractory shock with minimal respiratory symptoms (Riphagen et al., 2020) . Similar to 'classic' Kawasaki's disease, the children may have enlarged and aneurysmal coronary vessels on echocardiogram.

Testing results in the majority of children showed positive serology for SARS CoV-2, yet tested negative on PCR for active infection, suggesting this presentation is a delayed immune mediated response in children with history of prior infection (Viner and Whittaker, 2020) .

The patients with the highest risk of mortality are those have underlying health conditions that impacting their lung health (e.g. asthma, emphysema, smoking) and those with comorbidities that lower their overall health status (e.g. low Vit D, cancer, renal disease, diabetes and hypertension). Feng et al. suggest that these comorbidities stem from current angiotensin II receptor blocker medication therapy (Fang et al., 2020) . The current case fatality rate is calculated at approximately 2% (Fauci et al., 2020) . COVID-19 is already responsible for more fatalities than SARS CoV-1 and MERS combined (Mahase, 2020) . Although COVID-19 has a significantly lower case fatality rate than SARS CoV-1 (10%) and MERS (30%), this novel virus has the ability to spread undetected, through a prolonged asymptomatic incubation period, which increases the ability of transmission and by virtue increases the relative mortality rate. When comparing mortality across the affected countries, Italy has one of the highest death rates related to COVID-19. It is speculated early on that the advanced age of the population in Italy represented a unique factor in regard to susceptibility to severe respiratory illness Italy is known to have the oldest European population with over a quarter of people over the age of 65 (Rettner, 2020) .

The data on risk of vertical transmission in pregnant mothers continue to emerge (Schwartz and Graham, 2020) . Review of pregnancies and deliveries for COVID-19 positive mothers suggest low morbidity risk, with the most common complication being preterm delivery (Mullins et al., 2020) . Despite this, it is recommended that neonates and pregnant women implement precautions and avoid public places. The CDC currently recommends continuing breastfeeding as evidence does not show that the virus can be transferred through breastmilk.

Breastfeeding mothers with suspected infection should continue to practice proper hygiene and wear a mask while breastfeeding to avoid transference of respiratory particles (CDC, 2020).

Children and adolescents are susceptible to infection, but little is known regarding their risk status (Lee et al., 2020) . Similar precautions are in place for the adolescent population to protect against infection and spread (Schmitt, 2020) .

Avoidance of ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDS) has been suggested by French researchers, as studies show patients taking NSAIDS before becoming ill suffered from more severe pneumonia than those who had not (Day, 2020) . However, multiple studies have responded by stating not enough data exists to suggest poor outcomes based on NSAID use due to the complexity of the targeted cyclooxygenase pathway (FitzGerald, 2020; Giollo et al., 2020) . Switching from NSAIDS to acetaminophen is a reasonable alternative in healthy individuals requiring antipyretics until more data are available.

International collaborative scientific response Scientific collaborations have revealed that the cytopathic effects and poor prognosis are associated with increased release of cytokines such as Interleukin-6 (IL-6) and the discovery of the angiotensin converting enzyme 2 receptor (ACE2) serving as the infective portal of entry (Cai, 2020; Zhu et al., 2020; Letko and Munster, 2020) . The host virus uses its CoV S protein receptor binding motif to bind ACE2 in the target cell (Millet and Whittaker, 2015) . Injury is thought to occur by the downregulation of ACE2 in alveolar cells, which normally provide a protective function against lung injury (Xu et al., 2020) . Downregulation of ACE2 leads to downstream effects including upregulating type 1A ACE2 receptors and resulting in increased pulmonary vascular permeability (Imai et al., 2020) .

The use of quarantine dates back to the fourteenth century where Italian officials required ships to stay off port for 40 days in an effort to prevent the plague from entering mainland (CDC, 2020). The bubonic plague of the 14 th Century, also referred to as the black death pandemic, accounted for an estimated 50 to 100 million deaths across Eurasia (Frith, 2012) . To put this into perspective, approximately 60% of Europe's population was decimated by the disease (McEvedy, 2020). The responsible bacterium Yersinia pestis causes a prodrome stage of myalgias, fever and shortness of breath, along with characteristic buboes or swollen and tender lymph nodes (Cui and Song, 2016) . The most lethal form of the plague is spread through respiratory droplets from human to human transmission, resulting in a pneumonic plague that reaches a near 100% fatality rate (CDC, 2018 ). The World Health Organization (WHO) defines a pandemic as an infection that is able to sustain infectivity and spread across a global region and in which the human population has no immunity towards (Figure 2 ; Doshi, 2011) . Because of COVID-19s accelerated spread across multiple continents, global response for rapid intervention has focused on containment (WHO, 2020). Infectious diseases start out as endemics, meaning they infect a particular subpopulation at a stable and predictable rate (Grennan, 2019) . When the infection progresses to spread at an unpredictable rate, the disease is classified as an outbreak. Outbreaks evolve into epidemics once the virus spreads over a larger geographic region, and eventually pandemics at a global scale.

Pandemics can be broken down into six phases, starting with phase 1-3 which are defined as mostly animal infection with few human cases (WHO, 2020). Phase 4 is reached after sustained human to human transmission. Phase 5 and 6 is defined as meeting pandemic criteria with progressive global transmission and represents the current global phase of COVID-19, with some regions including the US experiencing post-peak transmission rates.

The United States Government has placed level 3 travel precautions on multiple countries including China, Iran, South Korea, United Kingdom and many European nations, effectively banning non-essential travel. Level 3 travel advisories are issued to discourage travel due to significant risks towards safety, health and security. American citizens looking to return to the United States are asked to self-quarantine at home for a 14-day time period (CDC, 2020). The government is not allowing foreign nationals that have visited Iran or China in the last 14 days to enter the country at this time. In an unprecedented move, the CDC had issued a 14 day domestic travel advisory for New York, New Jersey and Connecticut on March 30, asking citizens of these states to refrain from any travel (CDC, 2020).

Tourism and travel (trains, airplanes, and cruise ships) are associated with the highest risk of infection since these are generally highly concentrated areas with people that have visited multiple countries. Abstaining from visiting airports and cruise ships is recommended by the CDC (CDC, 2020). In addition, The Center for Disease Control and Prevention recommends maintaining household emergency plans. Families should consider alternatives to work and school in case local and federal governments call for a shutdown. A two-headed approach of prevention and containment offers the greatest intervention point with COVID-19. Individuals who believe they contracted COVID-19 who are clinically stable should remain home and selfquarantine for a 14 day minimum and make a telephone visit to determine if further medical care is required (CDC, 2020) . This reduces the risk of infecting the individuals at hospitals with chronic illness who are most susceptible to severe respiratory failure and alleviating the burden of overwhelming hospital personnel.

The greatest intervention in the COVID-19 pandemic is the application of effective preventative measures. Officials in Wuhan, China engaged in rapid preventative action and placed suspected patients on airborne precautions and issued fit-tested N-95 mask precautions to healthcare personnel . These respirators are named after their ability to filter over 95% of particles up to 0.3 microns in size, which covers SARS CoV-2 (Kirby, 2020).

Healthcare personnel have been directed to use appropriate personal protective equipment (PPE) such as N-95 respirator masks when caring for infected patient and triage of suspected cases.

The CDC issued guidelines for handwashing, household and workplace sanitation ( Table   2 ). The recommendation calls for handwashing using soap and warm water while scrubbing for a minimum of 20 seconds (US FDA, 2019). Alternatively, hand sanitizer can be effective in the absence of soap and water such as in public forums. It is recommended that all household and workplace areas be frequently disinfected using 75% alcohol products or disinfecting wipes.

Examples of places to clean include doorknobs, tables, counters, computer keyboards and more.

It is recommended that persons avoid touching the face (mouth, nose, or eyes) to prevent fomites from reaching high risk areas of the body. Additionally, avoid unnecessary travel to overcrowded locations (e.g. amusement parks, sports events, movie theatres, and hospitals) to reduce potential transmission burden. Self awareness and handwashing are critical as studies show the average human touches their face over 200 times per day (Kwok et al., 2015) . Similarly, social distancing practices should be implemented throughout the day (Table 3 ). The CDC defines social distancing as keeping 6 feet, (or two arms-lengths) away from the nearest person.

Fear of contracting COVID-19 led to large public demand for PPE, resulting in sparse supplies of masks and gloves. Standard surgical masks have been shown to be similarly effective in preventing infection in lower risk situations such as outdoor areas, as they provide a direct barrier of the nose and mouth and prevent incidental fomite contact (Derrick and Gomersall, 2005) . Studies from the original SARS CoV-1 epidemic recommend using absorbent (e.g. cotton) over disposable gowns, as the disposables allowed for longer virus survival (Cheng et al., 2007) . While the CDC and WHOs original stance did not call for masks for the general public, the recommendation came later from the state level for citizens to wear homemade versions of masks in public in order to spare medical grade surgical masks and N95 respirators for healthcare personnel. These masks should cover the mouth and nose entirely and be washed daily. A tutorial is provided on the CDC website with several creative methods to create a mask with cloth materials at home (CDC, 2020).

Supportive care is the mainstay treatment for respiratory distress in COVID-19, encompassing ventilation support to extracorporeal membrane oxygenation, while information is obtained regarding effective treatment for the COVID-19 infection. Researchers have looked to the treatment strategies gained by the analysis of the MERS and SARS outbreaks to get a better understanding of possible therapeutic regimens.

Two previous trials of systemic corticosteroids to address the high cytokine load did not improve mortality and instead caused a delay in viral clearance (Stockman et al., 2006; Arabi et al., 2018) . That said, a new clinical trial of methylprednisolone has recently been approved to see if COVID-19 cases respond (Harrison, 2020) . Switching to short term-moderate dose regimen of corticosteroids combined with immunoglobins improves oxygenation (Zhou et al., 2020) .

Many researchers suggest a trial of antiviral medications to help suppress viral replication, and both ritonavir and lopinavir are in clinical trials (Shionogi, Toyama Chemical; Clinical trials, 2020) . The use of these protease inhibitors were proven to be efficacious during the original SARS epidemic (Chu et al., 2004) . Remdesivir (Gilead Pharmaceuticals Inc, Foster City, CA) is an investigational drug that was considered as a treatment for Ebola but never FDA approved. It is currently being tested in clinical trials for efficacy against COVID-19. Select cases have shown remdesivir capable of shortening time until clinical improvement in patients suffering from COVID-19 (Grien et al., 2020) .

Hydroxychloroquine, a disease modifying antirheumatic drug has been considered as a potential option to treat those infected with COVID-19 who demonstrate cytokine storm, because it has the ability to sequester both innate and adaptive immunity, making it a powerful antiinflammatory agent (Schrezenmeier and Dorner, 2020) . This agent provides similar benefit in systemic lupus erythematous by attenuating the pro-inflammatory cascade (Tang et al., 2012) . A non-randomized clinical trial combining azithromycin and hydroxychloroquine initially showed promising therapeutic potential (Gautret et al., 2020) . The authors recommend risk stratification as the combination of drugs can potentiate cardiac arrythmias. Most recently, hydroxychloroquine has fallen out of favor as a therapeutic of choice because of significant side effect profile and lack of clear clinical benefit, followed with the retraction of a Lancet article supporting hydroxychloroquine (Chorin et al., 2020; Mehra et al., 2020) .

Additionally, the IL-6 human monoclonal antibody Tocilizumab is in a clinical trial for COVID-19 treatment (Chugai Pharmaceutical, Zhejiang Hisun Pharmaceutical, Jiangsu Qyun Bio-Pharmaceutical, Jiangsu, China). This novel use of a monoclonal antibody as an antiviral agent is suggested to work through its immunosuppression of acute phase reactants, which is associated with inflammation and leukocyte recruitment, which could potentially reduce respiratory distress. Another promising and emerging area of investigation is the use of convalescent plasma in patients with severe COVID-19 presentations. Early results suggest that this therapy may clear viremia by way of neutralizing antibodies from recovered donors (Duan et al., 2020) .

The utilization of the heavy metal Zinc has been postulated to improve outcome in patients with COVID-19 . The mechanism of action works through the interference of RNA viral replication (te Velthuis et al., 2010) .

No vaccine to date has been created to prevent COVID-19. Most recently, the National Institute of Health (NIH) announced on March 16 the start of phase 1 trials to evaluate an investigational vaccine of COVID-19 at the Kaiser Permanente Washington Heath Research Institute (Routh, 2020) . As of April 8, there are over 70 vaccine candidates in various stages of testing, with several trials entering phase 2 (Thanh et al., 2020). With a new public-private partnership between the NIH and multiple pharmaceutical company, all parties hope to accelerate the speed at which a vaccine is developed and tested for efficacy and safety to be utilized globally (Corey et al., 2020) .

COVID-19 remains a devastating pandemic that continues to threaten the health infrastructure.

Therapeutics continue to remain elusive as no gold standard therapy has emerged as the singular frontrunner in the treatment of symptomatic patients. Supportive care remains the mainstay of treatment as the total case number continues to rise. Reports on cutaneous manifestations of COVID-19 ranging from maculopapular exanthems to acral pernio-like lesions termed 'COVID toes' are emerging, offering additional diagnostic clues for earlier diagnosis and intervention. Table 1 : Cutaneous manifestations of COVID-19. 

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

A Strategic Approach to COVID-19 Vaccine R&D

Genome and Evolution of Yersinia pestis

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists

Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks

An interactive web-based dashboard to track COVID-19 in real time

The elusive definition of pandemic influenza

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Covid-19 -Navigating the Uncharted

Misguided drug advice for COVID-19

The history of plague-part 1: The three great pandemics

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Coronavirus disease 19 (Covid-19) and nonsteroidal anti-inflammatory drugs (NSAID)

The Lethal Spanish Influenza Pandemic in Poland

Compassionate Use of Remdesivir for Patients with Severe Covid-19

World Health Organization. Current WHO phase of pandemic alert for Pandemic (H1N1)

Clinical Characteristics of Coronavirus Disease 2019 in China

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

Coronavirus puts drug repurposing on the fast track

First case of 2019 novel coronavirus in the United States

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Angiotensin-converting enzyme 2 protects from severe acute lung failure

COVID-19 can present with a rash and be mistaken for dengue

Australian Government releases face masks to protect against coronavirus

COVID-19) infection-induced chilblains: A case report with histopathologic findings

Face touching: a frequent habit that has implications for hand hygiene

Chilblain-like lesions on feet and hands during the COVID-19 Pandemic

Are children less susceptible to COVID-19?

A major outbreak of severe acute respiratory syndrome in Hong Kong

Functional assessment of cell entry and receptor usage for lineage B βcoronaviruses, including 2019-nCoV

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

A dermatologic manifestation of COVID-19: Transient livedo reticularis

The Bubonic Plague

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

COVID-19 and Kawasaki Like Disease: The Known-Known, the Unknown-Known and the Unknown-Unknown

Coronavirus in pregnancy and delivery: rapid review

COVID-19 and Cutaneous manifestations

THE GEOGRAPHY AND MORTALITY OF THE 1918 INFLUENZA PANDEMIC

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

What are the risks of COVID-19 infection in pregnant women? The Lancet

Cutaneous manifestations in COVID-19: a first perspective

Acral cutaneous lesions in the Time of COVID-19

Why deaths from coronavirus are so high in Italy

Hyperinflammatory shock in children during COVID-19 pandemic

National Institutes of Health. NIH clinical trial of investigational vaccine for COVID-19 begins

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Cruise ship outbreak helps pin down how deadly the new coronavirus is

Cutaneous manifestations of COVID-19: Report of three cases and a review of literature

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

SARS: systematic review of treatment effects

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects

Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): a brief review

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

The COVID-19 vaccine development landscape

Kawasaki-like disease: emerging complication during the COVID-19 pandemic

World Health Organization. Coronavirus disease (COVID-19) travel advice

World Health Organization. Current WHO phase of pandemic alert for Pandemic (H1N1)

A new coronavirus associated with human respiratory disease in China

Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

Skin manifestations of COVID-19

Liver injury in COVID-19: management and challenges

Potential interventions for novel coronavirus in China: A systematic review

Short-Term Moderate-Dose Corticosteroid Plus Immunoglobulin Effectively Reverses COVID-19 Patients Who Have Failed Low-Dose Therapy

A novel coronavirus from patients with pneumonia in China

Cutaneous Manifestations of COVID-19

CDC hygienic steps to prevent spread  Keep your hands clean by washing with soap and water for at least 20 seconds or using a hand sanitizer with at least 60 percent alcohol  Avoid touching your eyes, nose, and mouth  Cover your coughs and sneezes with tissues or your arm/sleeve and dispose of tissues in the trash  Avoid people who are sick  Avoid sharing items like dishes and bedding and keep surfaces clean with disinfecting wipes  Wear a homemade mask whenever outside of home if risk of contact with others (e.g. groceries, gas, work)

1. Social gatherings When feasible, limit all gatherings to under 10 people. If not possible, keep 6 feet distance from nearest person. Wear a homemade mask whenever outside.

Avoid dine-in areas when possible. If necessary, use take-out/delivery options. Always wear a homemade mask covering mouth and nose when out in public.

Convert all physical meetings to virtual through video chat applications.4. Confined areas (e.g. elevators) Reduce exposure to confined areas such as elevators by using alternative measures such as stairways when possible.

Maintain 6-feet social distancing whenever encountering an individual that appears ill. Always wear a mask when taking care of sick persons.6. Unable to maintain social distancing Maintain proper hygiene by using disposable tissues or upper arm to cover sneeze or cough. Avoid touching unnecessary surfaces and use soap and water or hand sanitizer often.